Jonathan Kwan, MS
Prior to joining Harvard, Jonathan held a role as a CMC Scientist at an early stage non-viral gene therapy start-up, Summation Bio, to design and execute process development studies for particle manufacturing, formulation, and scalability. Prior to that, Jonathan worked as an Associate Scientist II in the Purification Development group in the Science and Technology department at AbbVie. There, he supported late phase biologics in GMP production suites as a purification subject matter expert, led downstream purification technology transfers, and performed platform process development studies at the lab scale. Jonathan received his M.S. and B.S. in Biomedical Engineering from Binghamton University.